#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Blastic plasmacytoid dendritic cell neoplasia Alagille syndrome Hyperoxaluria Red blood cell abnormality Hodgkin's disease recurrent Phaeochromocytoma Fatty acid oxidation disorder Chronic myeloid leukaemia (in remission) Oesophageal carcinoma Infantile apnoea Phenylketonuria Acromegaly Extranodal marginal zone B-cell lymphoma (MALT type) Chordoma Pelizaeus-Merzbacher disease More trials…

    Learn about Rare Diseases

    Mastocytosis – Life with Disease Wiskott-Aldrich syndrome – Basic Information Brain stem glioma – Diagnostics Noonan syndrome – Treatment Ehlers-Danlos syndrome – Life with Disease Hepatic angiosarcoma – Treatment Lymphangioma – Life with Disease Nephrotic syndrome – Life with Disease Turner’s syndrome – Diagnostics Vascular malformation – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-2060 Tofacitinib Ezabenlimab Dupilumab Desoximetasone Sodium Fluoride (18F) Mirabegron Bms-986449-03 Sertindole Water For Injection Durvalumab Falbikitug Ecoo1A Emibetuzumab Disodium Folinate MB-HUCART19.1 Nifedipine Eprosartan Mesilate Savolitinib Sapropterin Dihydrochloride More therapies…

    Learn about Your Condition

    Chordoma Biliary neoplasm Brain neoplasm Oropharyngeal cancer recurrent Pemphigus Radius fracture Lip and/or oral cavity cancer Hodgkin's disease refractory Febrile neutropenia Osteomyelitis acute Toxic nodular goitre Meniscus injury Colorectal adenocarcinoma Oral neoplasm Eclampsia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire De La Reunion

Centre Hospitalier Universitaire De La Reunion

Allee Des Topazes, Cs 11021, St Denis, 97400, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Pausing Treatment with Pembrolizumab and Axitinib in Patients with Metastatic Kidney Cancer at Good or Intermediate Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    • Cabozantinib
    • Lenvatinib
    France

  • Study on Adjuvant Treatment for Unilateral Retinoblastoma with Vincristine Sulfate and Drug Combination in Patients After Primary Eye Removal

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Carboplatin
    • Cyclophosphamide
    • Etoposide
    France

  • Study on Anifrolumab and Phototherapy for Adults with Progressive Vitiligo

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Anifrolumab
    France

  • Study of Nivolumab for Children and Adults with Relapsed or Refractory ALK+ Anaplastic Large Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaplastic large cell lymphoma T- and null-cell types
    Investigated Drugs:
    • Nivolumab
    Denmark France

  • Study of Setmelanotide for Patients with Obesity Due to Specific Genetic Variants

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Setmelanotide
    France Germany Greece The Netherlands Spain

  • Study of platinum, pemetrexed, atezolizumab and bevacizumab combination in patients with advanced non-small cell lung cancer who have EGFR, ALK or ROS1 mutations and progressed after targeted therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Carboplatin
    France

  • Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Ociperlimab
    • Pembrolizumab
    • Tislelizumab
    France Germany Italy The Netherlands Poland Spain

  • Study on Afamelanotide and NB-UVB Light for Vitiligo Treatment in Patients with Vitiligo

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Afamelanotide
    France Italy

  • Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amikacin
    • Azithromycin
    • Ethambutol Hydrochloride
    Austria Belgium Denmark France Germany Greece +5

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Amlitelimab
    • Pimecrolimus
    • Tacrolimus
    France Germany Greece Italy The Netherlands Poland +1
Previous Page
1 … 3 4 5 6 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!